I-High Purity Pharmaceutical Grade 179324-69-7 Bortezomib yokwelashwa kwe-Tumor
Umkhiqizoigama | I-Bortezomib |
Omqondofana | [(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic acid |
Inombolo ye-CAS. | 179324-69-7 |
Ukubukeka | Impushana emhlophe noma emhlophe |
I-Molecular Formula | C19H25BN4O4 |
Isisindo samangqamuzana | 384.24 |
Ukusetshenziswa | Ibanga lezemithi noma inhloso yocwaningo |
Ukupakisha | Njengesicelo sakho |
Isitoreji | Londoloza ezitsheni eziqinile, ezimelana nokukhanya endaweni epholile |
I-BortezomibI-CAS:179324-69-7 | ||
IZINTO | AMAZINGA | IMIPHUMELA |
Cumlingisi | Impushana emhlophe noma emhlophe | Impushana emhlophe |
Ukulahlekelwa ekomisweni | ≤1.0% | 0.25% |
Izinsimbi Ezisindayo | ≤20ppm | <20ppm |
Ukujikeleza kwe-Optical | -45°~-55° | -53.2° |
Izinto Ezihlobene | Ukungcola Okuphelele ≤ 1.0% | 0.09% |
Ukungcola okungashiwongo ≤ 0.10% | 0.02% | |
Izincibilikisi Ezisele | I-Methanol ≤ 0.3% I-Dichloromethane ≤ 0.06% I-Hexane ≤ 0.029% I-Ethyl acetate ≤ 0.5% | ND ND ND 0.030% |
I-ASSAY | ≥ 99.0% | 99.91% |
Isiphetho: Ihambisana ne-In-house standard. |
Ulwazi Lwenkampani
√ Isipiliyoni esigcwele se-Management layer kubalandeli befektri nabanekhono; √ Ikhwalithi ihlale iwukucatshangelwa kwethu okuphezulu, uhlelo oluqinile lwe-QC; √ Ithimba leminyaka engu-11 elinesipiliyoni sokuthumela ngaphandle; √ Ilebhu ye-R&D ezimele; √ Izinkundla zokucobelelana ngolwazi ezimbili ze-GMP zesikhathi eside ezisayiniwe; √ Izinsiza ezicebile zamafekthri amaningi angasebenzi wephrojekthi eyenziwe ngokwezifiso; √ Ithimba elisebenzayo elisebenza kahle elinendlela engaguquki.Bhala umyalezo wakho lapha futhi usithumelele wona